ISSN 2149-2263 | E-ISSN 2149-2271 Home      
 
Volume : 22 Issue : 3
Current Issue Archive Popular Article Ahead of Print

   
Quick Search





 
Distribution of Therapeutic Procedures and Use of Drug Therapies in Patients with Angiographically Confirmed Coronary Artery Disease [Anatol J Cardiol]
Anatol J Cardiol. 2002; 2(1): 18-23

Distribution of Therapeutic Procedures and Use of Drug Therapies in Patients with Angiographically Confirmed Coronary Artery Disease

Kenan Sönmez1, Mustafa Akçakoyun2, Durmuş Demir1, Orhan Hakan Elönü1, Özgür Onat1, Nilüfer Ekşi Duran1
1Koşuyolu Kalp Eğitim ve Araştırma Hastanesi Kardiyoloji Kliniği, İstanbul
2Koşuyolu Kalp Eğitim ve Araştırma Hastanesi, Kardiyoloji Bölümü, İstanbul

Objective: The aims of our study were to assess the distribution of interventional and other therapeutic procedures performed on subjects who had proven CAD by angiography in our clinic; to determine the groups of therapeutic agents prescribed at the time of discharge; and to compare these with the results of EUROASPIRE II, which examined the prophylactic drug therapy upon discharge of CAD patients in 15 European countries. Methods: Our patients comprises of 617 subjects (516 male, 101 female; mean age 57.2 ± 10.8 years) who underwent coronary angiography for the first time in our clinic and who were found to have a ≥50% lesion in at least one of the coronary arteries. In all patients distribution of risk factors on admission, distribution of therapeutic procedures and the use of drug therapies at the hospital discharge were recorded. Results: We found that, 68% of our cases were considered to be eligible for a percutaneous or surgical intervention, while 27% were assessed not as requiring such an intervention and consequently were discharged being prescribed appropriate medications. For the remaining 5% of the subjects, tests for detection of viable myocardium were advised, before selecting the proper type of management. At discharge, prescription rates for antiplatelets, beta-blockers, nitrates, statins, angiotensin-converting enzyme inhibitors (ACE-I), calcium channel blockers and anticoagulants were detected to be %99, 86%, 86%, 63%, 40%, 16%, and 2% respectively. Conclusion: Compared with the results of EUROASPIRE II study, these data show that, antiplatelet, beta-blocker, ACE-I and lipid-lowering treatments our subjects received upon discharge were higher, whereas anticoagulant treatment was lower than the averages of the fifteen European countries consisting the EUROASPIRE II study.



Kenan Sönmez, Mustafa Akçakoyun, Durmuş Demir, Orhan Hakan Elönü, Özgür Onat, Nilüfer Ekşi Duran. Distribution of Therapeutic Procedures and Use of Drug Therapies in Patients with Angiographically Confirmed Coronary Artery Disease. Anatol J Cardiol. 2002; 2(1): 18-23


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share


Similar articles
PubMed
Google Scholar




 
 
KARE Publishing | Copyright © 2018 Turkish Society of Cardiology